HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis.

AbstractOBJECTIVE:
To assess the relationship between pancreatic enzyme therapy (PET) and the clinical outcomes of growth, abdominal pain, constipation, gassiness, and number of stools in cystic fibrosis (CF).
STUDY DESIGN:
Patients (n = 1215) >4 weeks of age from 33 Cystic Fibrosis Foundation accredited sites who had a sweat chloride >60 mmol/L or two CF-causing mutations were enrolled using a proportionate sampling strategy in a nonblinded study. Patients submitted a stool sample and completed a questionnaire. The study coordinator also completed a questionnaire for each patient. Enzyme dosing and growth, abdominal pain, gassiness, constipation, and number of stools were compared.
RESULTS:
Of the 1215 enrolled patients, 1131 (93.1%) were prescribed PET. Only 14.9% had pancreatic function assessed before enrolling in this study. Stool elastase-1 analysis identified 1074 (89%) patients as pancreatic insufficient (PI). There was no association between PET and the outcomes: growth, abdominal pain, gassiness, constipation, and number of stools.
CONCLUSION:
PET dose is not correlated with growth or gastrointestinal symptoms. More sensitive outcome measures of the effectiveness of PET in patients with CF are needed to guide treatment of PI.
AuthorsSusan S Baker, Drucy Borowitz, Linda Duffy, Laura Fitzpatrick, Joyce Gyamfi, Robert D Baker
JournalThe Journal of pediatrics (J Pediatr) Vol. 146 Issue 2 Pg. 189-93 (Feb 2005) ISSN: 0022-3476 [Print] United States
PMID15689904 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pancreatic Elastase
Topics
  • Abdominal Pain (etiology)
  • Adolescent
  • Child
  • Child, Preschool
  • Constipation (etiology)
  • Cystic Fibrosis (complications, drug therapy)
  • Diarrhea (etiology)
  • Dose-Response Relationship, Drug
  • Exocrine Pancreatic Insufficiency (complications, drug therapy)
  • Humans
  • Infant
  • Pancreas (drug effects, physiopathology)
  • Pancreatic Elastase (therapeutic use)
  • Pancreatic Function Tests
  • Surveys and Questionnaires
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: